Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Accolade, Inc. - common stock (NQ:ACCD)

7.030 +0.020 (+0.29%)
Streaming Delayed Price Updated: 12:03 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,141,388
Open 7.020
Bid (Size) 7.020 (356)
Ask (Size) 7.030 (1,147)
Prev. Close 7.010
Today's Range 7.010 - 7.030
52wk Range 3.080 - 9.670
Shares Outstanding 76,232,192
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday
Ark Invest made notable trades on Feb. 28, 2025. They purchased shares in ACHR, RXRX, TEM, and IRDM, while selling shares in TWST, ADYEY, ACCD, and EXAS. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
ACCD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Accolade, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire

Performance

YTD
+105.6%
+105.6%
1 Month
+1.2%
+1.2%
3 Month
+105.6%
+105.6%
6 Month
+91.0%
+91.0%
1 Year
-24.9%
-24.9%

More News

Read More
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, FNA, LGTY, ACCD on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Accolade, Inc. (Nasdaq - ACCD), Paragon 28, Inc. (NYSE - FNA), Logility Supply Chain Solutions, Inc. (Nasdaq - LGTY), Enfusion, Inc. (NYSE - ENFN)
From Brodsky & Smith LLC
Via GlobeNewswire
Cathie Wood's Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursday
Via Benzinga
Cathie Wood's Ark Invest Bets On Biotech With CRISPR Therapeutics Investment, Exits Roblox
Via Benzinga
Cathie Wood's Wednesday Moves: Ark Invest Dumps Robinhood Stock
Via Benzinga
Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policies
Via Benzinga
Topics Government
Exposures Political
Accolade Q3 Earnings Assessment
Via Benzinga
Earnings Scheduled For January 9, 2025
Via Benzinga
Cathie Wood's Ark Invest Is Betting Big On This AI Darling And No It's Not Nvidia
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Enfusion, Inc. (NYSE - ENFN), Intra-Cellular Therapies, Inc. (Nasdaq - ITCI), Paycor HCM, Inc. (Nasdaq - PYCR), Accolade, Inc. (Nasdaq - ACCD)
From Brodsky & Smith LLC
Via GlobeNewswire
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates SSTK, ACCD, ESSA, AKYA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
What's Going On With Accolade Stock Wednesday?
Via Benzinga
Breaking Down Accolade: 8 Analysts Share Their Views
Via Benzinga
ACCOLADE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Accolade, Inc. - ACCD
From Kahn Swick & Foti, LLC
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Is Accolade Stock Trading Over 100% On Tuesday?
Via Benzinga
Shareholder Alert: Ademi LLP Investigates Whether Accolade, Inc. Is Obtaining a Fair Price for Its Public Shareholders
From Ademi LLP
Via Business Wire
Forecasting The Future: 6 Analyst Projections For Accolade
Via Benzinga
ACCD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Accolade, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Transcarent To Acquire Accolade
From Transcarent
Via Business Wire
Transcarent To Acquire Accolade
From Accolade, Inc.
Via GlobeNewswire
Accolade's Q2 Boost: Revenue Rises, Losses Shrink, And Profitability Looms
Via Benzinga
Accolade Announces Results for Fiscal Second Quarter 2025
From Accolade, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Accolade, Inc. - common stock publicly traded?
Yes, Accolade, Inc. - common stock is publicly traded.
What exchange does Accolade, Inc. - common stock trade on?
Accolade, Inc. - common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Accolade, Inc. - common stock?
The ticker symbol for Accolade, Inc. - common stock is ACCD on the Nasdaq Stock Market
What is the current price of Accolade, Inc. - common stock?
The current price of Accolade, Inc. - common stock is 7.030
When was Accolade, Inc. - common stock last traded?
The last trade of Accolade, Inc. - common stock was at 04/04/25 12:03 PM ET
What is the market capitalization of Accolade, Inc. - common stock?
The market capitalization of Accolade, Inc. - common stock is 535.91M
How many shares of Accolade, Inc. - common stock are outstanding?
Accolade, Inc. - common stock has 536M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.